MephamT.B., CombesR.D., BallsM., BarbieriO., BlokhuisH.J., CostaP., CrillyR.E., de Cock BuningT., DelpireV.C., O'HareM.J., HoudebineL-M., van KreijlC.F., van der MeerM., ReinhardtC.A., WolfE., & van ZellerA-M. (1998). The use of transgenic animals in the European Union. The report and recommendations of ECVAM workshop 28. ATLA26, 21–43.
2.
HMSO (1999). Statistics of Scientific Procedures on Living Animals. Great Britain 1998. Cm. 4418, 108 pp. London, UK: HMSO9). ECVAM workshop 28: a research perspective. ATLA27, 815–818.
3.
DeanS. (1999). ECVAM workshop 28: an industry perspective. ATLA27, 819–821.
4.
GriffinG., & GauthierC. (1999). Do Canadian Council on Animal Care Guidelines meet ECVAM recommendations on transgenic animals?ATLA27, 823–825.
5.
JenkinsE.S., & CombesR.D. (1999). Transgenic models for prion disease: have they outlived their useful purpose?ATLA27, 827–838.
6.
van ZellerA-M., & CombesR.D. (1999). Transgenic mouse assays for carcinogenicity testing: a step in the right direction?ATLA27, 839–846.
7.
MephamT.B., & CrillyR.E. (1999). Bioethical issues in the generation and use of transgenic farm animals. ATLA27, 847–855.
8.
van der MeerM., CostaP., BaumansV., OlivierB., & van ZutphenB. (1999). Welfare assessment of transgenic animals: behavioural responses and morphological development of newborn mice. ATLA27, 857–868.
9.
DelpireV.C., MephamT.B., & BallsM. (1999). A proposal for a new ethical scheme addressing the use of laboratory animals for biomedical purposes. ATLA27, 869–881.
10.
JenkinsE.S., & FrancisR.F. (1999). New guidance notes for projects generating or maintaining genetically modified animals. ATLA27, 883–902.
11.
GAEB (1996). Group of Advisers to the European Commission on the Ethical Implications of Biotechnology, 24 pp. Luxembourg: Office for the Official Publications of the European Communities.